BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32998950)

  • 21. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
    Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC
    Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
    Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
    Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.
    Butt J; Varga MG; Blot WJ; Teras L; Visvanathan K; Le Marchand L; Haiman C; Chen Y; Bao Y; Sesso HD; Wassertheil-Smoller S; Ho GYF; Tinker LE; Peek RM; Potter JD; Cover TL; Hendrix LH; Huang LC; Hyslop T; Um C; Grodstein F; Song M; Zeleniuch-Jacquotte A; Berndt S; Hildesheim A; Waterboer T; Pawlita M; Epplein M
    Gastroenterology; 2019 Jan; 156(1):175-186.e2. PubMed ID: 30296434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori strain types and risk of gastric cancer: a case-control study.
    Enroth H; Kraaz W; Engstrand L; Nyrén O; Rohan T
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):981-5. PubMed ID: 11008919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.
    Aziz F; Gao W; Yan Q
    Pathol Oncol Res; 2017 Jan; 23(1):173-179. PubMed ID: 27757838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between Helicobacter pylori CagA status and colorectal cancer.
    Shmuely H; Passaro D; Figer A; Niv Y; Pitlik S; Samra Z; Koren R; Yahav J
    Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.
    Camargo MC; Beltran M; Conde-Glez CJ; Harris PR; Michel A; Waterboer T; Carolina Flórez A; Torres J; Ferreccio C; Sampson JN; Pawlita M; Rabkin CS
    Int J Cancer; 2015 Dec; 137(12):3000-5. PubMed ID: 26178251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
    Mitchell HM; Hazell SL; Li YY; Hu PJ
    Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity.
    Loh JT; Shaffer CL; Piazuelo MB; Bravo LE; McClain MS; Correa P; Cover TL
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2237-49. PubMed ID: 21859954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving epidemiology of Helicobacter pylori infection and gastric cancer.
    Huang JQ; Hunt RH
    Can J Gastroenterol; 2003 Jun; 17 Suppl B():18B-20B. PubMed ID: 12845346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between cagA-positive Helicobacter pylori infection and risk of gastric cancer: a case control study in Porto Alegre, RS, Brazil.
    Meine GC; Rota C; Dietz J; Sekine S; Prolla JC
    Arq Gastroenterol; 2011; 48(1):41-5. PubMed ID: 21537541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host pathogen interactions in
    Chmiela M; Karwowska Z; Gonciarz W; Allushi B; Stączek P
    World J Gastroenterol; 2017 Mar; 23(9):1521-1540. PubMed ID: 28321154
    [No Abstract]   [Full Text] [Related]  

  • 40. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
    Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
    World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.